Lack of association between migraine headache and patent foramen ovale: Results of a case-control study

Circulation

Volumn 121, Issue 12, 2010, Pages 1406-1412

  Garg, Pallav ^a,c   Servoss, Stephen J ^e   Wu, Justina C ^a,c   Bajwa, Zahid H ^b,c   Selim, Magdy H ^b,c   Dineen, Alexis ^g   Kuntz, Richard E ^f   Cook, E Francis ^d   Mauri, Laura ^a,c,h  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b Beth Israel Deaconess Medical Center   (Israel)

^c HARVARD MEDICAL SCHOOL   (United States)

^d HARVARD SCHOOL OF PUBLIC HEALTH   (United States)

^e Bartzokis Seckler and Rubenstein Medical Practice   (United States)

^f MEDTRONIC INC   (United States)

^g Cierra Inc   (United States)

^h HARVARD CLINICAL RESEARCH INSTITUTE   (United States)

Author keywords

Echocardiography; Epidemiology; Migraine; Patent foramen ovale

Indexed keywords

SODIUM CHLORIDE;

ADULT; AGED; ARTICLE; CASE CONTROL STUDY; CLINICAL TRIAL; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE ASSOCIATION; DOPPLER ECHOGRAPHY; DOPPLER FLOWMETRY; EVALUATION; FEMALE; HEADACHE; HUMAN; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MIGRAINE; MIGRAINE WITH AURA; PATENT FORAMEN OVALE; PREVALENCE; PRIORITY JOURNAL; RISK; STANDARD; TRANSTHORACIC ECHOCARDIOGRAPHY; VALSALVA MANEUVER;

ADULT; CASE-CONTROL STUDIES; ELECTROCARDIOGRAPHY; FEMALE; FORAMEN OVALE, PATENT; HUMANS; MALE; MIDDLE AGED; MIGRAINE DISORDERS; ODDS RATIO; PREVALENCE; ULTRASONOGRAPHY, DOPPLER, TRANSCRANIAL;

EID: 77950220918     PISSN: 00097322     EISSN: 15244539     Source Type: Journal    
DOI: 10.1161/CIRCULATIONAHA.109.895110     Document Type: Article

References (37)

1. Lipton RB, Stewart WF, Diamond S, Diamond ML, Reed M. Prevalence and burden of migraine in the United States: data from the American Migraine Study II. Headache. 2001;41:646-657.
2. Stewart WF, Shechter A, Rasmussen BK. Migraine prevalence: a review of population-based studies. Neurology. 1994;44:S17-S23.
3. Lipton RB, Bigal ME, Diamond M, Freitag F, Reed ML, Stewart WF. Migraine prevalence, disease burden, and the need for preventive therapy. Neurology. 2007;68:343-349.
4. Fisher DC, Fisher EA, Budd JH, Rosen SE, Goldman ME. The incidence of patent foramen ovale in 1,000 consecutive patients: a contrast trans-esophageal echocardiography study. Chest. 1995;107:1504-1509.
5. Hagen PT, Scholz DG, Edwards WD. Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts. Mayo Clin Proc. 1984;59:17-20.
6. Di Tullio MR, Sacco RL, Sciacca RR, Jin Z, Homma S. Patent foramen ovale and the risk of ischemic stroke in a multiethnic population. J Am Coll Cardiol. 2007;49:797-802.
7. Rundek T, Elkind MS, Di Tullio MR, Carrera E, Jin Z, Sacco RL, Homma S. Patent foramen ovale and migraine: a cross-sectional study from the Northern Manhattan Study (NOMAS). Circulation. 2008;118: 1419-1424.
8. Lamy C, Giannesini C, Zuber M, Arquizan C, Meder JF, Trystram D, Coste J, Mas JL. Clinical and imaging findings in cryptogenic stroke patients with and without patent foramen ovale: the PFO-ASA Study. Stroke. 2002;33:706-711.
9. Anzola GP, Magoni M, Guindani M, Rozzini L, Dalla Volta G. Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study. Neurology. 1999;52:1622-1625.
10. Del Sette M, Angeli S, Leandri M, Ferriero G, Bruzzone GL, Finocchi C, Gandolfo C. Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study. Cerebrovasc Dis. 1998;8:327-330.
11. Kimmelstiel C, Gange C, Thaler D. Is patent foramen ovale closure effective in reducing migraine symptoms? A controlled study. Catheter Cardiovasc Interv. 2007;69:740-746.
12. Post MC, Thijs V, Herroelen L, Budts WI. Closure of a patent foramen ovale is associated with a decrease in prevalence of migraine. Neurology. 2004;62:1439-1440.
13. Reisman M, Christofferson RD, Jesurum J, Olsen JV, Spencer MP, Krabill KA, Diehl L, Aurora S, Gray WA. Migraine headache relief after transcatheter closure of patent foramen ovale. J Am Coll Cardiol. 2005; 45:493-495.
14. Schwerzmann M, Wiher S, Nedeltchev K, Mattle HP, Wahl A, Seiler C, Meier B, Windecker S. Percutaneous closure of patent foramen ovale reduces the frequency of migraine attacks. Neurology. 2004;62: 1399-1401.
15. Azarbal B, Tobis J, Suh W, Chan V, Dao C, Gaster R. Association of interatrial shunts and migraine headaches: impact of transcatheter closure. J Am Coll Cardiol. 2005;45:489-492.
16. Schwedt TJ, Demaerschalk BM, Dodick DW. Patent foramen ovale and migraine: a quantitative systematic review. Cephalalgia. 2008;28: 531-540.
17. Kurth T, Tzourio C, Bousser MG. Migraine: a matter of the heart? Circulation. 2008;118:1405-1407.
18. Dowson A, Mullen MJ, Peatfield R, Muir K, Khan AA, Wells C, Lip-scombe SL, Rees T, De Giovanni JV, Morrison WL, Hildick-Smith D, Elrington G, Hillis WS, Malik IS, Rickards A. Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache. Circulation. 2008;117:1397-1404.
19. Stewart WF, Lipton RB, Kolodner K. Migraine Disability Assessment (MIDAS) score: relation to headache frequency, pain intensity, and headache symptoms. Headache. 2003;43:258-265.
20. Lipton RB, Stewart WF, Sawyer J, Edmeads JG. Clinical utility of an instrument assessing migraine disability: the Migraine Disability Assessment (MIDAS) questionnaire. Headache. 2001;41:854-861.
21. Daniels C, Weytjens C, Cosyns B, Schoors D, De Sutter J, Paelinck B, Muyldermans L, Van Camp G. Second harmonic transthoracic echocar-diography: the new reference screening method for the detection of patent foramen ovale. Eur J Echocardiogr. 2004;5:449-452.
22. Attaran RR, Ata I, Kudithipudi V, Foster L, Sorrell VL. Protocol for optimal detection and exclusion of a patent foramen ovale using trans-thoracic echocardiography with agitated saline microbubbles. Echocar-diography. 2006;23:616-622.
23. Anzola GP, Frisoni GB, Morandi E, Casilli F, Onorato E. Shunt-associated migraine responds favorably to atrial septal repair: a case-control study. Stroke. 2006;37:430-434.
24. Dubiel M, Bruch L, Schmehl I, Liebner M, Winkelmann A, Stretz A, Grad MO, Kleber FX. Migraine headache relief after percutaneous trans-catheter closure of interatrial communications. J Interv Cardiol. 2008;21: 32-37.
25. Wilmshurst PT, Nightingale S, Walsh KP, Morrison WL. Clopidogrel reduces migraine with aura after transcatheter closure of persistent foramen ovale and atrial septal defects. Heart. 2005;91:1173-1175.
26. Bigal ME, Ferrari M, Silberstein SD, Lipton RB, Goadsby PJ. Migraine in the triptan era: lessons from epidemiology, pathophysiology, and clinical science. Headache. 2009;49(suppl 1):S21-S33.
27. Goadsby PJ. The vascular theory of migraine: a great story wrecked by the facts. Brain. 2009;132:6-7.
28. Silberstein SD. Recent developments in migraine. Lancet. 2008;372: 1369-1371.
29. Ferrari MD. Migraine. Lancet. 1998;351:1043-1051.
30. Gervil M, Ulrich V, Kaprio J, Olesen J, Russell MB. The relative role of genetic and environmental factors in migraine without aura. Neurology. 1999;53:995-999.
31. Ulrich V, Gervil M, Kyvik KO, Olesen J, Russell MB. Evidence of a genetic factor in migraine with aura: a population-based Danish twin study. Ann Neurol. 1999;45:242-246.
32. Goadsby PJ, Charbit AR, Andreou AP, Akerman S, Holland PR. Neuro-biology of migraine. Neuroscience. 2009;161:327-341.
33. Scher AI, Terwindt GM, Picavet HS, Verschuren WM, Ferrari MD, Launer LJ. Cardiovascular risk factors and migraine: the GEM population-based study. Neurology. 2005;64:614-620.
34. Tietjen GE. Migraine as a systemic vasculopathy. Cephalalgia. 2009;29: 987-996.
35. Sloan MA, Alexandrov AV, Tegeler CH, Spencer MP, Caplan LR, Feldmann E, Wechsler LR, Newell DW, Gomez CR, Babikian VL
36. Lefkowitz D, Goldman RS, Armon C, Hsu CY, Goodin DS. Assessment: transcranial Doppler ultrasonography: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology. 2004;62:1468-1481.
37. Clarke NR, Timperley J, Kelion AD, Banning AP. Transthoracic echocardi-ography using second harmonic imaging with Valsalva manoeuvre for the detection of right to left shunts. Eur J Echocardiogr. 2004;5:176-181